Maintenance doses for most patients fall between 1 mg and 2.4 mg weekly, though some benefit from doses outside this range
This allows for more gradual dose adjustments to minimize side effects and optimize weight loss outcomes
Compared to other weight loss drugs, using GLP-1 agonists increases the risk of pancreatitis (inflammation of the pancreas) by 9 times, bowel obstruction (blockage of the small or large intestines) by 4.5 times, and gastroparesis (a condition that slows or stops the movement of food from the stomach to the small intestine) by 3.6 times
They help adjust your treatment to fit your health needs and progress towards your weight goals
Thats because its safe and effective, has been widely studied (been around longer), and has relatively few side effects
That boundary should remain clear even when several signals appear together on one timeline